Pure Himalayan Shilajit - Get 50% Off X
Esiflo 125 Transhaler, a prescription drug, is manufactured in various forms such as Inhaler. Esiflo 125 Transhaler also has some secondary and off-label uses. These are listed below.
The correct dosage of Esiflo 125 Transhaler depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Esiflo 125 Transhaler include Shortness of Breath, Throat Irritation, Nosebleed. Besides the aforementioned side effects, there are other adverse effects of Esiflo 125 Transhaler as well, which are listed below. Normally, these side effects of Esiflo 125 Transhaler are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Esiflo 125 Transhaler's effect during pregnancy is Moderate and Mild while nursing. In addition, Esiflo 125 Transhaler's effects on the liver, heart and kidney are discussed below in the Esiflo 125 Transhaler related warnings section.
Other conditions have been mentioned below in the Esiflo 125 Transhaler contraindications section.
Drug reaction of Esiflo 125 Transhaler with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Esiflo 125 Transhaler is considered safe while driving, and is addictive.
Esiflo 125 Transhaler is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Esiflo 125 Transhaler is used -
Moderate
Mild
Common
Unknown
Is the use of Esiflo 125 Transhaler safe for pregnant women?
Esiflo can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Esiflo right away. Take your doctor's advice before taking it again.
Is the use of Esiflo 125 Transhaler safe during breastfeeding?
Breastfeeding women can take Esiflo as it bears very minor side effects for them.
What is the effect of Esiflo 125 Transhaler on the Kidneys?
Using Esiflo does not have any harmful effects on kidneys.
What is the effect of Esiflo 125 Transhaler on the Liver?
You may experience side effects on your liver after taking Esiflo. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Esiflo 125 Transhaler on the Heart?
Esiflo can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Esiflo 125 Transhaler should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Esiflo 125 Transhaler unless your doctor advises you to do so -
Is this Esiflo 125 Transhaler habit forming or addictive?
Esiflo 125 Transhaler does not cause addiction.
Interaction between Food and Esiflo 125 Transhaler
There is no information on the effects of taking Esiflo 125 Transhaler with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Esiflo 125 Transhaler
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Esiflo 125 Transhaler.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359